Waters (NYSE:WAT – Get Free Report) updated its second quarter 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 2.880-2.980 for the period, compared to the consensus EPS estimate of 2.930. The company issued revenue guidance of $744.0 million-$758.1 million, compared to the consensus revenue estimate of $739.0 million. Waters also updated its FY 2025 guidance to 12.750-13.050 EPS.
Wall Street Analysts Forecast Growth
WAT has been the topic of several research analyst reports. Wells Fargo & Company boosted their price target on Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a research note on Thursday, February 13th. Baird R W upgraded shares of Waters from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 26th. UBS Group raised their price target on shares of Waters from $405.00 to $410.00 and gave the stock a “neutral” rating in a research report on Thursday, February 13th. Robert W. Baird cut their price objective on shares of Waters from $407.00 to $355.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 22nd. Finally, Scotiabank upgraded shares of Waters from a “sector perform” rating to a “sector outperform” rating and boosted their target price for the company from $430.00 to $450.00 in a research report on Thursday, February 13th. Ten investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $392.13.
Check Out Our Latest Analysis on Waters
Waters Stock Performance
Waters (NYSE:WAT – Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. As a group, research analysts forecast that Waters will post 12.86 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Waters
A hedge fund recently raised its stake in Waters stock. Brighton Jones LLC boosted its holdings in shares of Waters Co. (NYSE:WAT – Free Report) by 112.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,269 shares of the medical instruments supplier’s stock after acquiring an additional 673 shares during the period. Brighton Jones LLC’s holdings in Waters were worth $471,000 at the end of the most recent reporting period. Institutional investors own 94.01% of the company’s stock.
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Recommended Stories
- Five stocks we like better than Waters
- What does consumer price index measure?
- Chevron’s Fundamentals Shine Through Market Turmoil
- How to Use the MarketBeat Dividend Calculator
- Qualcomm: Analyst Opinions Split, But Upside Potential Remains
- What to Know About Investing in Penny Stocks
- Monster Beverage Stock: Short Report Risks vs Upside Potential
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.